Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2015 16:01 ET | Source: TESARO, Inc.

TESARO to Announce Fourth-Quarter 2014 Financial Results on February 19, 2015

WALTHAM, Mass., Feb. 5, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its fourth-quarter 2014 financial results on Thursday, February 19, 2015, after the close of the U.S....
February 05, 2015 16:01 ET | Source: TESARO, Inc.

TESARO to Present at the Leerink Global Healthcare Conference

WALTHAM, Mass., Feb. 5, 2015 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Leerink Global Healthcare Conference at the Waldorf...
January 12, 2015 11:53 ET | Source: TESARO, Inc.

CORRECTING and REPLACING -- TESARO Announces Expansion of Niraparib Clinical Program and Outlines Late-Stage Program Milestones for 2015

-- New trial of niraparib for the treatment of ovarian cancer to begin in Q1 2015 -- HRD assay to be incorporated into Phase 3 NOVA trial of niraparib in ovarian cancer -- Initial...
January 12, 2015 08:00 ET | Source: TESARO, Inc.

TESARO Announces Expansion of Niraparib Clinical Program and Outlines Late-Stage Program Milestones for 2015

-- New trial of niraparib for the treatment of ovarian cancer to begin in Q1 2015 -- HRD assay to be incorporated into Phase 3 NOVA trial of niraparib in ovarian cancer -- Initial...
December 02, 2014 05:15 ET | Source: TESARO, Inc.

TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate

--Candidate Will Target Two Undisclosed Immune Checkpoints --Anti-TIM-3 Antibody Data to be Presented Today at the AACR Conference in Orlando WALTHAM, Mass. and SAN DIEGO, Dec. 2, 2014 (GLOBE...
November 25, 2014 17:00 ET | Source: TESARO, Inc.

TESARO to Present at the 2014 Deutsche Bank BioFEST

WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present at the 2014 Deutsche Bank BioFEST...
November 25, 2014 08:00 ET | Source: TESARO, Inc.

TESARO to Present at the Nasdaq 31st Investor Program

WALTHAM, Mass., Nov. 25, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Nasdaq 31st Investor Program on Tuesday, December...
November 12, 2014 08:00 ET | Source: TESARO, Inc.

TESARO to Present at the Jefferies 2014 Global Healthcare Conference

WALTHAM, Mass., Nov. 12, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, will present at the Jefferies 2014 Global Healthcare Conference on...
November 05, 2014 16:01 ET | Source: TESARO, Inc.

TESARO Announces Third-Quarter 2014 Operating Results

Oral Rolapitant New Drug Application (NDA) Accepted for Review by U.S. FDA Enrollment in Niraparib NOVA Trial Non-gBRCA Cohort on Track to Be Complete at Year End Anti-LAG-3 Clinical...
October 22, 2014 16:01 ET | Source: TESARO, Inc.

Tesaro to Announce Third-Quarter 2014 Financial Results on November 5, 2014

WALTHAM, Mass., Oct. 22, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) will announce its third-quarter 2014 financial results on Wednesday, November 5, 2014, after the close of the U.S....